Matches in Wikidata for { <http://www.wikidata.org/entity/Q85305392> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q85305392 description "article scientifique publié en 2012" @default.
- Q85305392 description "artículu científicu espublizáu n'ochobre de 2012" @default.
- Q85305392 description "scientific article published on 26 October 2012" @default.
- Q85305392 description "wetenschappelijk artikel" @default.
- Q85305392 description "наукова стаття, опублікована в жовтні 2012" @default.
- Q85305392 name "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI" @default.
- Q85305392 name "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI" @default.
- Q85305392 type Item @default.
- Q85305392 label "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI" @default.
- Q85305392 label "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI" @default.
- Q85305392 prefLabel "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI" @default.
- Q85305392 prefLabel "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI" @default.
- Q85305392 P1433 Q85305392-E363680C-649D-4BEA-A582-2CD4972492C1 @default.
- Q85305392 P1476 Q85305392-20AEB72D-FF0B-4E3D-B0D4-11127218470F @default.
- Q85305392 P2093 Q85305392-42167863-D2CC-4B2B-84EF-E0B472F4CFF4 @default.
- Q85305392 P2093 Q85305392-53587A61-9599-4C92-8FC1-ABAC9E74574F @default.
- Q85305392 P2093 Q85305392-77595DC6-D9E6-4440-AAD5-ECC78267EDD4 @default.
- Q85305392 P2093 Q85305392-78D30362-0FE0-4AEE-9B21-484380B26980 @default.
- Q85305392 P2093 Q85305392-9F115AF2-7194-4EA2-8146-65AF96952F1B @default.
- Q85305392 P2093 Q85305392-BAEA93C6-E528-40ED-990C-277A01CEEBB5 @default.
- Q85305392 P2093 Q85305392-C578D3E2-892C-4DAB-88B2-E94A711CEF3D @default.
- Q85305392 P2093 Q85305392-EB3589CA-9B3F-45F7-BCBD-49F327FA85BF @default.
- Q85305392 P304 Q85305392-ACD34E1D-C9DF-4010-A57C-626B27A204E3 @default.
- Q85305392 P31 Q85305392-2830E3E9-2F21-48C6-BB0F-1AAD420CDC64 @default.
- Q85305392 P356 Q85305392-6EF3303D-CDC4-4996-A34B-8F7F52488780 @default.
- Q85305392 P433 Q85305392-6EFC88DC-D26E-4629-9865-DB20A882B277 @default.
- Q85305392 P478 Q85305392-7170C851-02BB-4DDD-A369-87394E521D92 @default.
- Q85305392 P50 Q85305392-3A69FE13-1CAF-440E-9A4E-12DDA7DAE839 @default.
- Q85305392 P50 Q85305392-AF59B59B-F733-40A3-812C-3FBCFBCC486E @default.
- Q85305392 P577 Q85305392-33FF0111-309E-4C59-B4B7-01EB7FD2F36C @default.
- Q85305392 P698 Q85305392-4A6BE90A-4739-4AC8-A66C-84FE6E4AD31C @default.
- Q85305392 P921 Q85305392-0F239AD4-61AC-40C6-9D07-1F4B1A72C536 @default.
- Q85305392 P921 Q85305392-A45A5C7B-149C-43C6-982C-F05612C52197 @default.
- Q85305392 P356 J.IJCARD.2012.09.093 @default.
- Q85305392 P698 23106905 @default.
- Q85305392 P1433 Q2357863 @default.
- Q85305392 P1476 "Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI" @default.
- Q85305392 P2093 "Dae-Kyeong Kim" @default.
- Q85305392 P2093 "Dong-Soo Kim" @default.
- Q85305392 P2093 "Han-Young Jin" @default.
- Q85305392 P2093 "Hyung Jun Kim" @default.
- Q85305392 P2093 "Jeong-Sook Seo" @default.
- Q85305392 P2093 "Kyu-Nam Choi" @default.
- Q85305392 P2093 "Sang-Ryul Chung" @default.
- Q85305392 P2093 "Tae-Hyun Yang" @default.
- Q85305392 P304 "207-211" @default.
- Q85305392 P31 Q13442814 @default.
- Q85305392 P356 "10.1016/J.IJCARD.2012.09.093" @default.
- Q85305392 P433 "1" @default.
- Q85305392 P478 "168" @default.
- Q85305392 P50 Q116762706 @default.
- Q85305392 P50 Q41566718 @default.
- Q85305392 P577 "2012-10-26T00:00:00Z" @default.
- Q85305392 P698 "23106905" @default.
- Q85305392 P921 Q18216 @default.
- Q85305392 P921 Q410237 @default.